
Anixa Biosciences ANIX
€ 2.54
-2.26%
Geschäftsbericht 2025
hinzugefügt 12.01.2026
Anixa Biosciences P/CF 2011-2026 | ANIX
P/CF Jährlich Anixa Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.0144 | -0.00965 | -0.0243 | -0.0211 | -12.2 | 2.44 K | -15.4 | -16 | -7.97 | -15.5 | 20.7 | -17.1 | -14.2 | -12.7 | -32.9 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.44 K | -32.9 | 154 |
P/CF anderer Aktien in der Diagnostik & Forschung
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | ||
|
Castle Biosciences
CSTL
|
10.9 | $ 39.83 | 1.7 % | $ 1.11 B | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
Brainsway Ltd.
BWAY
|
271 | $ 23.52 | -2.2 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-40.2 | $ 34.0 | 0.68 % | $ 366 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M | ||
|
Exact Sciences Corporation
EXAS
|
44.3 | $ 102.43 | 0.13 % | $ 19 B | ||
|
Fulgent Genetics
FLGT
|
22.2 | $ 26.13 | -0.44 % | $ 790 M | ||
|
BioNano Genomics
BNGO
|
-0.0515 | $ 1.3 | -11.56 % | $ 1.65 M | ||
|
Guardant Health
GH
|
-24.4 | $ 111.99 | 1.37 % | $ 13.7 B | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
-1.58 | - | - | $ 79.8 M | ||
|
Danaher Corporation
DHR
|
22.7 | $ 218.32 | -0.59 % | $ 160 B | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
11.9 | $ 66.61 | -0.1 % | $ 4.61 B | ||
|
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.63 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
DexCom
DXCM
|
65.2 | $ 73.22 | -1.05 % | $ 28.3 B | ||
|
NeoGenomics
NEO
|
217 | $ 11.91 | -3.95 % | $ 1.51 B | ||
|
CareDx, Inc
CDNA
|
-28.3 | $ 20.33 | -2.26 % | $ 1.09 B | ||
|
Celcuity
CELC
|
-4.78 | $ 108.09 | -3.59 % | $ 4.26 B | ||
|
DarioHealth Corp.
DRIO
|
-1.43 | $ 10.14 | -1.55 % | $ 288 M | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Personalis
PSNL
|
-5.62 | $ 9.27 | -7.02 % | $ 549 M | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
19.6 | $ 144.04 | -3.77 % | $ 22.9 B | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
IQVIA Holdings
IQV
|
13.1 | $ 229.24 | -2.71 % | $ 41.6 B | ||
|
Charles River Laboratories International
CRL
|
11.6 | $ 208.45 | -1.53 % | $ 10.7 B | ||
|
Thermo Fisher Scientific
TMO
|
23.7 | $ 575.61 | -2.79 % | $ 220 B | ||
|
Trinity Biotech plc
TRIB
|
9.03 | $ 0.81 | -7.96 % | $ 61.9 M | ||
|
Twist Bioscience Corporation
TWST
|
-32.8 | $ 40.92 | -1.59 % | $ 2.45 B | ||
|
Medpace Holdings
MEDP
|
16.7 | $ 581.54 | -1.94 % | $ 18 B | ||
|
Quest Diagnostics Incorporated
DGX
|
14.3 | $ 185.97 | 1.99 % | $ 20.6 B | ||
|
Biodesix
BDSX
|
-1.89 | $ 9.61 | -0.57 % | $ 1.25 B | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
Precipio
PRPO
|
-2.44 | $ 24.39 | 0.54 % | $ 31.7 M | ||
|
Laboratory Corporation of America Holdings
LH
|
13.3 | $ 269.91 | 0.04 % | $ 22.6 B | ||
|
Mettler-Toledo International
MTD
|
30.9 | $ 1 376.67 | -1.16 % | $ 29.2 B | ||
|
ICON Public Limited Company
ICLR
|
12.9 | $ 179.26 | -3.57 % | $ 14.8 B | ||
|
IDEXX Laboratories
IDXX
|
40.5 | $ 673.4 | -0.49 % | $ 55.5 B |